dc.description.abstract | Object:This study was conducted to determine the current prescription patterns of Chinese Herb Medicine May Containing Plant Species of the Genus Aristolochia in National Health Insurance in Taiwan between 1997-2001. and explore the different of prescription patterns between Taiwan’s regular using and Belgian’s Chinese herbs nephropathy cases. Method:The database containing 200,000 people randomly sampled from the National Health Insurance (NHI) system during 1997-2001 was used. The retrospective cohort was stratified for age, gender, cumulative prescribing days of mixtures containing Si-sin、Fang-ji、Mu-tong、Mu-siang、tian-sian-teng and Ma-dou-ling. Result:103630 people used Chinese medicine service and had 5098390 prescriptions between 1997-2001. There were 64216 people taking 361333 prescriptions containing these six kinds of drug, with a mean prescribing age of 37.9±19.3 and 76964 prescriptions between 35-44 years old. Using incidence rate of hole people is 64.2*10-3Year-1.Female gender is more than male. The mixture contain Si-Sin is the highest. All other kinds of mixtures had the most popular age range between 35-44 expecting Si-sin is under the 15 years old. 5999 prescriptions of six kinds of mixture had individual prescribing day more than eight days. The mean age of first time taking prescription of seven mixtures are 34.9±18.8 years old; all had the most popular age range between 35-44 expecting Si-sin is under the 15 and tian-sian-teng is between 25-34 years old. The cumulative prescribing day of all seven kinds of mixture is 32.9±56.1 days; 46355 people were less than 30 days. 5089 people had cumulative prescribing day more than 3 months. Conclusion:In Taiwan, the Chinese Herb Containing Plant Species of the Genus Aristolochia is no more used expect Si-sin. Our study find the using of mixture contain Si-sin is popular. Although the cumulative prescribing day is not as long as Belgian’s cases, Sin-Sin is frequently used in children under 15 years old. They may have lower danger dose than adult and has much long life time for cumulative dose. It is very crucial to further clarify the effect of Si-Sin on kidney function and urinary cancer in the future. | en |
dc.relation.reference | 1、中醫藥委員會,九十二年十一月四號公告,中醫藥委員會全球資訊網http://www.ccmp.gov.tw/index-c/1.htm (2003/11/27)
2、Kessler DA. Cancer and herbs. New Engl J Med 2000;342:1742-3.
3、FDA(U.S),Dietary Supplements, Center for Food Safety & Applied Nutrition website http://vm.cfsan.fda.gov/~dms/ds-bot.html (2003/11/27)
4、Vanherweghem JL,Depierreux M,Tielemans C, et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 1993; 341:387-91.
5、Cosyns JP,Jadoul M,Squifflet JP, et al. Chinese herbs nephropathy: a clue to Balkan endemic nephropathy ? Kidney Int 1994; 45:1680-8.
6、Reginster F,Jadoul M, van Ypersele de Strihou C. Chinese herbs nephropathy presentation, natural history, and fate after transplantation. Nephrol Dial Transplant 1997; 12:81-6.
7、Vanherweghem JL,Abramowicz D, Tielemans C, Depierreux M.Effects of steroids on the progression of renal failure in chronic interstitial renal fibrosis: a pilot study on Chinese herbs nephropathy. Am J Kidney Dis 1996; 27 : 209-15.
8、Lebeau C, Arlt VM, Schmeiser HH, et al. Aristolochic acid impedes endocytosis and induces DNA adducts in proximal tubule cell. Kidney Int 2001; 60:1332-42.
9、Morrissey JJ, Ishidoya S, McCracken R, et al. The effect of ACE inhibitors on the expression of matrix genes and the role of p53 and p21(WAF21) in experimental renal fibrosis. Kidney Int 1996; 49 (54 suppl.): 83S-7S.
10、IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Some traditional Herbal Medicines, some mycotoxins, naphthalene and styrene. IARC monographs on the evaluation of carcinogenic risks, Vol. 82. Lyon : International Agency for Research on Cancer. 2002. p.69.
11、Nortier JL, Muniz Martinez MC, Schmeiser HH et al, Urothelial carcinoma associated with the use of a Chinese herb. New Engl J Med 2000; 342:1686-1692.
12、Lord GM, Tagore R, Cook T, et al. Nephropathy caused by Chinese herbs in the UK. Lancet 1999; 354: 481-2.
13、Yang CS, Lin CH, Chang SH, Hsu HC, Rapidly progressice interstitial renal fibrosis associated Chinese herbal drug. Am J Kidney Dis 2000; 35: 313-8.
14、Chen HY, Ma B-Y, Grant A, et al. Time to abandon the term ‘Chinese herbs nephropathy’ Kidney Int 2001; 60: 2039-40.
15、Solez K, Daugirdas J, Gregory MC. Et al. Is ‘Chinese herbs nephropathy’ a prejudicial term [letter]. Kidney Int 2001; 38: 1141-2.
16、Cosyns JP. When is‘aristolochic acid nephropathy’ more accurate than ‘Chinese herbs nephropathy’? Kidney int 2002; 61:1178-81.
17、中央健康保險局,統計資料,中央健康保險局全球資訊網http://www.nhi.gov.tw/01intro/intro_3.htm (2003/11/27)
18、Yang CH, Lin CH, Chang SH, Hsu HC. Rapidly progressove initerstitial renal fibrosiss associated Chinese herbal drug. Am J Kidney Dis 2000;35:313-8
19、吳松寒:木通所致急性腎功能衰竭2例報告。江蘇中醫 1964;10:12-14。
20、劉金生、李金田:中藥中毒2例報告。江西中醫藥 1984;5,57-58。
21、劉金湖、曾漢基:大量煎服關木通致急性腎功能衰竭死亡一例。中國中醫藥雜誌 1994;19: 692。
22、黎磊石:由木通腎毒性研究帶來的思考.腎臟病與透析腎移植雜誌,1999;8:1-2。
23、諶貽璞,陳文:馬兜鈴酸腎病存在四種臨床病理類型。中華腎臟病雜 2000;16:406-407。
24、Brain S. What is pharmacoepidemiology. In Brain S. ed., Pharmacoepidemiology. Chichester: John Wiley& Sons Ltd 2000; 3-15.
25、國家衛生研究院,承保抽樣歸人檔,全民健康保險研究資料庫全球資訊網http://www.nhri.org.tw/nhird/date_cohort.htm (2004/12/3)
26、國家衛生研究院,各檔間串檔變項說明,全民健康保險研究資料庫全球資訊網http://www.nhri.org.tw/nhird/file_talk/connect2.jpg(2004/12/3)
27、工研院生醫中心,台灣中草藥市場,醫藥工業資訊網 http://biomed.itri.org.tw/market/cmedicine/cmedicine06.asp(2005/04/18)
28、中醫藥委員會,基準方劑,中醫藥資訊網全球資訊網http://www.ccmp.gov.tw/index-c/1.htm(2004/12/3)
29、中央健康保險局,健保用藥品項,中央健康保險局全球資訊網http://www.nhi.gov.tw/02hospital/hospital_6_01.htm(2004/12/3)
30、李承華、周穎政、陳龍生、張鴻仁:全民健保中醫門診利用率及其影響因素。台灣衛誌 2004;23:100-107。
31、徐雅慧、羅吉方、張憲昌、林哲輝:市售細辛藥材之鑑別。藥物食品檢驗局調查研究年報 2003;21:153-167。
32、Jong TT. Lee MR. Hsiao SS. Hsai JL. Wu TS. Chiang ST. Cai SQ. Analysis of aristolochic acid in nine sources of Xixin, a traditional Chinese medicine, by liquid chromatography/atmospheric pressure chemical ionization/tandem mass spectrometry. J Pharm Biomed Anal 2003; 33(4): 831-7.
33、黃淑貞、余萬能:社區藥局與診所取藥病人遵醫囑行為研究。公共衛生 2001;27:245-60。 | zh_TW |